Navigation path

Pharmaceuticals - Union Register

  

Register of orphan medicinal products


GRANTED  

Product information

Antisense oligonucleotide targeting the USH2A gene

EU orphan designation number: EU/3/17/1853   
Active ingredient: Antisense oligonucleotide targeting the USH2A gene
Indication: Treatment of retinitis pigmentosa
Sponsor: ProQR Therapeutics IV BV
Zernikedreef 9, 2333 CK Leiden, Nederland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/03/2017 Orphan designation EMA/OD/280/16 (2017)1981 of 20/03/2017